治疗细胞癌变异性组织学变异的管理
Luciana Chagas Prado1, Albert Jang2,3, Milena S Tariki4
1Universidade Professor Edson Antônio Velano (UNIFENAS), Alfenas, MG, Brazil.
JCO oncology practice
|October 21, 2025
概括
非清细胞细胞癌 (nccRCC) 在管理方面存在各种挑战. 本综述指导了nccRCC亚型的临床实践,强调了新的全身疗法和正在进行的试验.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生殖尿道癌症 生殖尿道癌症
背景情况:
- 非清细胞细胞癌 (nccRCC) 包含了一组异质的癌.
- nccRCC的管理是复杂的,通常依赖于清晰细胞RCC (ccRCC) 治疗指南.
- 了解nccRCC亚型对于有效的患者护理至关重要.
研究的目的:
- 为提供nccRCC的综合性审查,按组织学亚型结构化.
- 根据最近的临床试验数据指导nccRCC的临床管理.
- 总结nccRCC的流行病学,分子特征和诊断考虑.
主要方法:
- 对nccRCC最近的临床试验进行系统审查.
- 对nccRCC亚型的流行病学数据和分子特征的分析.
- 对nccRCC的当前诊断和管理策略的综合.
主要成果:
- 组合疗法 (免疫检查点抑制剂,向疗法) 在先进的nccRCC中表现有前途.
- 化疗仍然是特定亚型的标准,如收藏管癌和髓癌.
- 一些临床试验正在积极研究针对nccRCC.的新疗法.
结论:
- nccRCC需要特定于子类型的管理策略.
- 系统治疗的进步为患有晚期nccRCC的患者提供了新的希望.
- 持续的研究和临床试验对于改善nccRCC的结果至关重要.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...


